ArriVent’s Nasdaq debut nabs $175M as signs indicate an opening IPO window

The latest stories trending on MedCity News.

Editor's Pick

Top Story ArriVent's Nasdaq Debut Nabs $175M as Signs Indicate an Opening IPO Window ArriVent BioPharma will apply the IPO cash toward furmonertinib, which the biotech says could offer advantages over Takeda Pharmaceutical and Johnson & Johnson drugs that address the same lung cancer target. It's the second biotech IPO of this week, following CG Oncology. Sponsored Content Achieving Operational Improvement Through Improved Awareness Levels Presented by Care Logistics Exceptional awareness levels help hospitals improve operational efficiency and can also help health systems increase capacity, improve access to care, achieve higher profitability and improve margins.  Learn more! Calling Startups and Accelerators Do you focus on oncology, cardiology, women's health, or burnout and operational efficiency? If so, then apply to pitch at INVEST 2024. There is no fee to apply and each track will feature six finalists. This is the perfect way to make new connections, find investors/get additional funding, and a chance to win $20K in advertising for your startup. Deadline to apply is February 29, 2024. Apply Today

Featured News

Mitotic Counting Reimagined: When AI Meets the Microscope The shift towards digital pathology has marked a significant advancement in breast cancer diagnosis. High-resolution digital imaging of slides provides pathologists with an unprecedentedly clear and expansive view of tissue samples for their analysis. How Are Payers Approaching Obesity Management? GLP-1s continue to be in high demand, and the healthcare industry is watching closely to see how payers decide to cover the drugs going forward. During a virtual panel, payer executives noted that it's important to remember that GLP-1s won't be able to solve the country's obesity crisis by themselves. UnitedHealthcare Launches Resource To Help Members Access Health Programs UnitedHealthcare recently launched UHC Hub, which helps self-funded employers manage multiple health solutions and employees gain access to these solutions.

Resources

How To Enable a Hyperpersonal Care Experience This on-demand webinar features expert panelists from Praia Health and Providence, interviewed by AVIA to discuss the benefits of adopting a hyperpersonal care model for patients, barriers that hold health systems back, and will unpack Praia Health's technology capabilities. Watch Now

MedCity News • PO Box 901 • New York, NY unsubscribe